Related Experiment Video
Updated: Jun 3, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma
Elena N Voropaeva1,2, Yuriy L Orlov3,4, Anastasia B Loginova2
1Research Institute of Internal and Preventive Medicine - Branch of the Federal State Budget Scientific Institution "The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences", Novosibirsk, Russia.
Abstract:
Here, we have discussed the molecular mechanisms of p53-responsive microRNAs dysregulation in response to genotoxic stress in diffuse large B-cell lymphoma (DLBCL) patients. The role of micro ribonucleic acids (microRNAs) in p53-signaling cellular stress has been studied. MicroRNAs are the small non-coding RNAs, which regulate genes expression at post-transcriptional level. Many of them play a crucial role in carcinogenesis and may act as oncogenes or suppressor of tumor growth. The understanding of the effect of p53-responsive microRNA dysregulation on oncogenesis achieved in recent decades opens wide opportunities for the diagnosis, prediction and of microRNA-based cancer therapy. Development of new bioinformatics tools and databases for microRNA supports DLBCL research. We overview the studies on the role of miRNAs in regulating gene expression associated with tumorigenesis processes, with particular emphasis on their role as tumor growth-suppressing factors. The starting point is a brief description of the classical microRNA biogenesis pathway and the role of p53 in regulating the expression of these molecules. We analyze various molecular mechanisms leading to this dysregulation, including mutations in the TP53 gene, DNA methylation, changes in host-genes expression or microRNA gene copy number, mutations in microRNA and microRNA biogenesis genes.
Insights
Dysregulation of p53-responsive microRNAs (miRNAs) is implicated in diffuse large B-cell lymphoma (DLBCL) development. Understanding these molecular mechanisms offers new avenues for miRNA-based diagnostics and therapeutics in DLBCL.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
- miRNAs play critical roles in carcinogenesis, acting as oncogenes or tumor suppressors.
- The p53 tumor suppressor protein influences cellular stress responses, including miRNA expression.
Purpose of the Study:
- To discuss the molecular mechanisms of p53-responsive microRNA dysregulation in diffuse large B-cell lymphoma (DLBCL).
- To explore the role of microRNAs in p53-mediated cellular stress and oncogenesis.
- To highlight opportunities for miRNA-based diagnosis, prediction, and therapy in DLBCL.
Main Methods:
- Overview of microRNA biogenesis and the role of p53.
- Analysis of molecular mechanisms causing miRNA dysregulation in DLBCL.
- Review of studies on miRNA roles in tumorigenesis, focusing on tumor suppression.
Main Results:
- Genotoxic stress in DLBCL involves dysregulation of p53-responsive microRNAs.
- Mechanisms include TP53 gene mutations, DNA methylation, altered host gene expression, and copy number variations.
- Mutations in miRNA genes and their biogenesis pathways also contribute to dysregulation.
Conclusions:
- Understanding miRNA dysregulation in DLBCL provides insights into oncogenesis.
- miRNA-based approaches show promise for DLBCL diagnosis and treatment.
- Bioinformatics tools and databases are crucial for advancing DLBCL research on microRNAs.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
14:57Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Related Concept Videos
Abnormal Proliferation
MicroRNAs
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Intrinsic Apoptotic Pathway
Positive Regulator Molecules